Dendrimer biocompatibility and toxicity

Advanced Drug Delivery Reviews

Volumn 57, Issue 15, 2005, Pages 2215-2237

  Duncan, Ruth ^a   Izzo, Lorella ^a,b  

^a CARDIFF UNIVERSITY   (United Kingdom)

^b UNIVERSITY OF SALERNO   (Italy)

Author keywords

Biocompatibility; Biomedical use; Dendrimer; Dendron; Polymer therapeutic; Toxicity

Indexed keywords

BIOCOMPATIBILITY; BIOMEDICAL ENGINEERING; DRUG PRODUCTS; TOXICITY; VECTORS;

BIOMEDICAL USE; DENDRON; POLYMER THERAPEUTICS;

DENDRIMERS;

ALPHA CYCLODEXTRIN; ANGIOSTATIN; ANTIVIRUS AGENT; ASTRAMOL; BUTYLENEDIAMINE; DENDRIMER; DOXORUBICIN; FCE 28068; GADOMER 17; GLUCOSE 6 SULFATE; HEMPA; INDOMETACIN; MACROGOL; N ACETYLGLUCOSAMINE; NANOPARTICLE; OLIGONUCLEOTIDE; POLYAMIDOAMINE; POLYAMIDOAMINE G3; POLYAMIDOAMINE G4; POLYAMIDOAMINE G5; POLYAMIDOAMINE G7; POLYAMIDOAMINE POLY(ETHYLENEGLYCOL) POLYAMIDOAMINE; POLYETHYLENEGLYCOL POLYESTER; POLYFECT; POLYLYSINE; POLYMER; POLYPROPYLENEIMINE; POVIDONE; PROPRANOLOL; PROTEIN FOS; STARBURST; SUPERFECT; TISSUE INHIBITOR OF METALLOPROTEINASE 2; TRANSACTIVATOR PROTEIN; UNCLASSIFIED DRUG; UNINDEXED DRUG; VIVAGEL;

BIOCOMPATIBILITY; CELL FATE; CELL LINE; CELL VIABILITY; CLINICAL TRIAL; COMPLEMENT ACTIVATION; CYTOKINE RELEASE; CYTOTOXICITY; DRUG DELIVERY SYSTEM; DRUG SAFETY; DRUG TARGETING; ENDOCYTOSIS; HEMOLYSIS; HUMAN; IMMUNOGENICITY; INTESTINE; NONHUMAN; PARTICLE SIZE; PRIORITY JOURNAL; REVIEW; TOXICITY TESTING;

ANIMALS; BIOCOMPATIBLE MATERIALS; CACO-2 CELLS; CELL SURVIVAL; CHEMOKINES; COMPLEMENT ACTIVATION; CYTOKINES; DENDRIMERS; HEMOLYSIS; HUMANS; POLYAMINES; TISSUE DISTRIBUTION;

EID: 28744445460     PISSN: 0169409X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.addr.2005.09.019     Document Type: Review

References (146)

1. R. Duncan, Targeting and intracellular delivery of drugs. in: R.A. Meyers (Ed). Encyclopedia of Molecular Cell Biology and Molecular Medicine, WILEY-VCH, Weinheim, Germany, pp. 163-204.
2. S. Svenson, and D.A. Tomalia Dendrimers in biomedical applications Adv. Drug Del. Rev. 57 2005 2104 2127
3. R. Duncan, S. Dimitrijevic, and E.G. Evagorou The role of polymer conjugates in the diagnosis and treatment of cancer S.T.P. Pharma. Sci. 6 1996 237 263
4. R. Duncan The dawning era of polymer therapeutics Nat. Rev. Drug Discov. 2 2003 347 360
5. J.M. Harris, and R.B. Chess Effect of pegylation on pharmaceuticals Nat. Rev. Drug Discov. 2 2003 214 221
6. R. Duncan Polymer-drug conjugates D. Budman H. Calvert E. Rowinsky Handbook of Anticancer Drug Development 2003 Lippincott, Williams & Wilkins Philadelphia, USA 239 260
7. E. Wagner, J. Kloeckner, Gene delivery using polymer therapeutics, Adv. Polym. Sci. (in press).
8. U.C. Herborn, J. Barkhausen, I. Paetsch, P. Hunold, M. Mahler, K. Shamsi, and E. Nagel Coronary arteries: contrast-enhanced MR Imaging with SH L 643A- experience in 12 volunteers Radiology 229 2003 217 223
9. D.I. Bernstein, N. Bourne, N.K. Ayisi, J. Ireland, B. Matthews, T. McCarthy, and S. Sacks Evaluation of formulated dendrimer SPL7013 as a microbicide Antivir. Res. 57 3 2003 89 (Sp. Issue)
10. R. Duncan N-(2-hydroxypropyl) methacrylamide copolymer conjugates G.S. Kwon Polymeric Drug Delivery Systems 2005 Marcel Dekker, Inc. New York 1 92
11. P. Ohana, O. Gofrit, S. Ayesh, W. Al-Sharef, A. Mizrahi, T. Birman, T. Schneider, I. Matouk, N. de Groot, E. Tavdy, A.A. Sidi, and A. Hochberg Regulatory sequences of the H19 gene in DNA based therapy of bladder Gene Ther. Mol. Biol. 8 2004 181 192
12. E. Buhleier, W. Wehner, and F. Vogtle "Cascade" and "nonskid-chain-like" synthesis of molecular cavity topologies Synthesis 55 1978 155 158
13. D.A. Tomalia, H. Baker, J. Dewald, M. Hall, G. Kallos, S. Martin, J. Roeck, J. Ryder, and P. Smith A new class of polymers: starburst-dendritic macromolecules Polym. J. 17 1985 117 132
14. C.J. Hawker, and J.M.J. Frechet Preparation of polymers with controlled molecular architecture - a new approach to dendritic macromolecules J. Am. Chem. Soc. 112 1990 7638 7647
15. G.R. Newkome, C.N. Moorefield, and F. Vögtle Dendritic Molecules 1996 VCH Publishers Inc. New York 1 261
16. A.-M. Caminade, R. Laurent, and J.-P. Majoral Characterisation of dendrimers Adv. Drug Del. Rev. 57 2005 2128 2144
17. F. Aulenta, W. Hayes, and S. Rannard Dendrimers: a new class of nanoscopic containers and delivery devices Eur. Polym. J. 39 2003 1741 1771
18. S.-E. Stiriba, H. Frey, and R. Haag Dendritic polymers in biomedical applications: from potential to clinical use in diagnostics and therapy Angew. Chem., Int. Ed. 41 2002 1329 1334
19. U. Boas, and P.M.H. Heegaard Dendrimers in drug research Chem. Soc. Rev. 33 2004 43 63
20. J.F.G.A. Jansen, E.M.M. de Brabander-van den Berg, and E.W. Meijer Encapsulation of guest molecules into a dendritic box Science 266 1994 1226 1229
21. D.A. Tomalia, A.M. Naylor, and W.A. Goddard III Starburst dendrimers: molecular level control of size, shapes, surface chemistry, topology and flexibility from atoms to macroscopic matter Angew. Chem., Int. Ed. 29 1990 138 175
22. J.M.J. Frechet Dendrimers and hyperbranched polymers: two families of three-dimensional macromolecules with similar but clearly distinct properties J. Mater. Sci. Pure Appl. Chem. 33 1996 1399 1425
23. J. Roovers, and B. Comanita Dendrimers and dendrimer-polymer hybrids Adv. Polym. Sci. 142 1999 179 228
24. D.A. Tomalia, D.M. Hedstrand, and M.S. Ferritto Comb-burst dendrimer topology. New macromolecular architecture derived from dendritic grafting Macromolecules 24 1991 1435 1438
25. D.A. Tomalia, and I. Majoros Dendrimeric supramolecular and supromacromolecular assemblies A. Ciferri Supramolecular Polymers 2001 Marcel Dekker New York 359 433
26. S.M. Grayson, and J.M.J. Frechet Convergent dendrons and dendrimers: from synthesis to applications Chem. Rev. 101 2001 3819 3867
27. A.D. Schlueter, and J.P. Rabe Dendronized polymers: synthesis, characterization, assembly at interfaces, and manipulation Angew. Chem., Int. Ed. 39 2000 864 883
28. I. Gitsov, K.L. Wooley, C.J. Hawker, P.T. Ivanova, and J.M.J. Frechet Synthesis and properties of novel linear-dendritic block copolymers. Reactivity of dendritic macromolecules toward linear polymers Macromolecules 26 1993 5621 5627
29. H. Ihre, O.L. Padilla De Jesus, F.C.J. Szoka, and J.M.J. Frechet Polyester dendritic systems for drug delivery applications: design, synthesis, and characterization Bioconjug. Chem. 13 2002 443 452
30. O.L. Padilla de Jesus, H. Ihre, L. Gagne, J.M.J. Frechet, and F.C.J. Szoka Polyester dendritic systems for drug delivery applications: in vitro and in vivo evaluation Bioconjug. Chem. 13 2002 453 461
31. P.J.A. Borm Particle toxicology: from coal mining to nanotechnology Inhal. Toxicol. 14 2002 311 324
32. J. Giles Size matters when it comes to safety, report warns Nature 430 2004 599
33. R. Esfand, and D.A. Tomalia Poly(amidoamine) PAMAM dendrimers: from biomimicry to drug delivery and biomedical applications Drug Discov. Today 6 2001 427 436
34. J.M.J. Frechet, and D.A. Tomalia Dendrimers and Other Dendritic Polymers 2001 Wiley Chichester 647
35. C.Y. Guo, H. Wang, Y.H. Lin, and Q.L. Cai Application of Starburst (TM) PAMAM dendrimers as DNA carriers in vitro Prog. Biochem. Biophys. 31 2004 804 811
36. M.E. Mackay Dendrimers, nanodevices to create unique phenomena Comptes Rendus Chimie 6 2003 747 754
37. M.J. Cloninger Biological applications of dendrimers Curr. Opin. Chem. Biol. 6 2002 742 748
38. M.X. Tang, C.T. Redemann, and F.C. Szoka Jr. In vitro gene delivery by degraded polyamidoamine dendrimers Bioconjug. Chem. 7 1996 703 714
39. J.F. Kukowska-Latallo, A.U. Bielinska, J. Johnson, R. Spindler, D.A. Tomalia, and J.R. Baker Efficient transfer of genetic material into mammalian cells using Starburst polyamidoamine dendrimers Proc. Natl. Acad. Sci. U. S. A. 93 1996 4897 4902
40. A. Bielinska, J.F. Kukowska-Latallo, J. Johnson, D.A. Tomalia, and J.R. Baker Regulation of in vitro gene expression using antisense oligonucleotide or antisense expression plasmids transfected using starburst PAMAM dendrimers Nucleic Acids Res. 24 1996 2176 2182
41. A.J. Hollins, M. Benboubetra, Y. Omidi, B.H. Zinselmeyer, A.G. Schatzlein, I.F. Uchegbu, and S. Akhtar Evaluation of generation 2 and 3 poly(propylenimine) dendrimers for the potential cellular delivery of antisense oligonucleotides targeting the epidermal growth factor receptor Pharm. Res. 21 2004 458 466
42. F. Kihara, H. Arima, T. Tsutsumi, F. Hirayama, and K. Uekama In vitro and in vivo gene transfer by an optimized alpha-cyclodextrin conjugate with polyamidoamine dendrimer Bioconjug. Chem. 14 2003 342 350
43. M. Hussain, M.S. Shchepinov, M. Sohail, I.F. Benter, A.J. Hollins, E.M. Southern, and S. Akhtar A novel anionic dendrimer for improved cellular delivery of antisense oligonucleotides J. Control. Release 99 2004 139 155
44. T. Kim, H.J. Seo, J.S. Choi, H.S. Jang, J. Baek, K. Kim, and J.S. Park PAMAM-PEG-PAMAM: novel triblock copolymer as a biocompatible and efficient gene delivery carrier Biomacromolecules 5 2004 2487 2492
45. H. Nakanishi, O. Mazda, E. Satoh, H. Asada, H. Morioka, T. Kishida, M. Nakao, Y. Mizutani, A. Kawauchi, M. Kita, J. Imanishi, and T. Miki Non viral genetic transfer of Fas ligand induced significant growth suppression and apoptotic tumor cell death in prostate cancer in vivo Gene Ther. 10 2003 434 442
46. T. Okuda, S. Kidoaki, M. Ohsaki, Y. Koyama, K. Yoshikawa, T. Niidome, and H. Aoyagi Time-dependent complex formation of dendritic poly(l-lysine) with plasmid DNA and correlation with in vitro transfection efficiencies Org. Biomol. Chem. 1 2003 1270 1273
47. J. Roesnecker, S. Naundorf, S.W. Gersting, R.W. Hauck, A. Gessner, P. Nicklaus, R.H. Muller, and C. Rudolph Interaction of bronchoalveolar lavage fluid with polyplexes and lipoplexes: analysing the role of proteins and glycoproteins J. Gene Med. 5 2003 49 60
48. N. Malik, E.G. Evagorou, and R. Duncan Dendrimer-platinate: a novel approach to cancer chemotherapy Anti-Cancer Drugs 10 1999 767 776
49. R.F. Barth, D.M. Adams, A.H. Soloway, F. Alam, and M.V. Darby Boronated starburst-monoclonal antibody immunoconjugates: evaluation as a potential delivery system for neutron capture therapy Bioconjug. Chem. 5 1994 58 66
50. R.F. Barth, G. Wu, W.L. Yang, P.J. Binns, K.J. Riley, H. Patel, J.A. Coderre, W. Tjarks, A.K. Bandyopadhyaya, B.T.S. Thirumamagal, M.J. Ciesielski, and R.A. Fenstermaker Neutron capture therapy of epidermal growth factor (plus) gliomas using boronated cetuximab (IMC-C225) as a delivery agent Appl. Radiat. Isotopes 61 2004 899 903
51. W.L. Yang, R.F. Barth, G. Wu, A.K. Bandyopadhyaya, B.T.S. Thirumamagal, W. Tjarks, P.J. Binns, K. Riley, H. Patel, J.A. Coderre, M.J. Ciesielski, and R.A. Fenstermaker Boronated epidermal growth factor as a delivery agent for neutron capture therapy of EGF receptor positive gliomas Appl. Radiat. Isotopes 61 2004 981 985
52. L.P. Balogh, S.S. Nigavekar, L.Y. Sung, P. Balogh, X.Y. Shi, A.T. Cook, L.D. Minc, and M.K. Khan Development of radioactive gold-dendrimer nanocomposite devices to treat tumor microvasculature: synthesis and biodistribution J. Nucl. Med. 44 2003 1094 (Suppl. S)
53. H.S. Kim, E.S. Han, N. Sato, L.S. Park, K.J. Wong, J.A. Carrasquillo, and C.H. Paik Synthesis and evaluation of [I-125]-labeled biotinylated dendrimer for antibody pretargeting J. Nucl. Med. 44 5 2003 1091 (Suppl. S)
54. Y.G. Du, G.F. Gu, Y.X. Hua, G.H. Wei, X.S. Ye, and G.L. Yu Synthesis and antitumor activities of glucan derivatives Tetrahedron 60 2004 6345 6351
55. K. Kono, M. Liu, and J.M.J. Frechet Design of dendritic macromolecules containing folate or methotrexate residues Bioconjug. Chem. 10 1999 1115 1121
56. W.K. Moon, Y.H. Lin, T. O'Loughlin, Y. Tang, D.E. Kim, R. Weissleder, and C.H. Tung Enhanced tumor detection using a folate receptor-targeted near-infrared fluorochrome conjugate Bioconjug. Chem. 14 2003 539 545
57. A.K. Patri, A. Myc, J. Beals, T.P. Thomas, N.H. Bander, and J.R. Baker Synthesis and in vitro testing of J591 antibody-dendrimer conjugates for targeted prostate cancer therapy Bioconjug. Chem. 15 2004 1174 1181
58. L. Vincent, J. Varet, J.Y. Pille, H. Bompais, P. Opolon, A. Maksimenko, C. Malvy, M. Mirshahi, H. Lu, J.P.V.C. Soria, and H. Li Efficacy of dendrimer-mediated angiostatin and TIMP-2 gene delivery on inhibition of tumor growth and angiogenesis: in vitro and in vivo studies Int. J. Cancer 105 2003 419 429
59. L. Vannucci, A. Fiserova, K. Sadalapure, T.K. Lindhorst, M. Kuldova, P. Rossmann, O. Horvath, V. Kren, P. Krist, K. Bezouska, M. Luptovcova, F. Mosca, and M. Pospisil Effects of N-acetyl-glucosamine-coated glycodendrimers as biological modulators in the B16F10 melanoma model in vivo Int. J. Oncol. 23 2003 285 296
60. H. Kobayashi, S. Kawamoto, J. Konishi, S. Jo, M.W. Brachbiel, and R.A. Star Macromolecular MRI contrast agents with small dendrimer cores for functional kidney imaging Radiology 225 2002 237
61. H. Kobayashi, S.K. Jo, S. Kawamoto, H. Yasuda, X.Z. Hu, M.V. Knopp, M.W. Brechbiel, P.L. Choyke, and R.A. Star Polyamine dendrimer-based MRI contrast agents for functional kidney imaging to diagnose acute renal failure J. Magn. Reson. Imaging 20 2004 512 518
62. S. Langereis, Q.G. de Lussanet, M.H.P. van Genderen, W.H. Backes, and E.W. Meijer Multivalent contrast agents based on gadolinium- diethylenetriaminepentaacetic acid-terminated poly(propylene imine) dendrimers for magnetic resonance imaging Macromolecules 37 2004 3084 3091
63. S.J. Wang, M. Brechbiel, and E.C. Wiener Characteristics of a new MRI contrast agent prepared from polypropyleneimine dendrimers, generation 2 Invest. Radiol. 38 2003 662 668
64. H. Kobayashi, K. Reijnders, S. English, A.T. Yordanov, D.E. Milenic, A.L. Sowers, D. Citrin, M.C. Krishna, T.A. Waldmann, J.B. Mitchell, and M.W. Brechbiel Application of a macromolecular contrast agent for detection of alterations of tumor vessel permeability induced by radiation Clin. Cancer Res. 10 2004 7712 7720
65. H. Kobayashi, S. Kawamoto, Y. Sakai, P.L. Choyke, R.A. Star, M.W. Brechbiel, N. Sato, Y. Tagaya, J.C. Morris, and T.A. Waldmann Lymphatic drainage imaging of breast cancer in mice by micro-magnetic resonance lymphangiography using a nano-size paramagnetic contrast agent J. Natl. Cancer Inst. 96 2004 703 708
66. A.T. Yordanov, H. Kobayashi, S.J. English, K. Reijnders, D. Milenic, M.C. Krishna, J.B. Mitchell, and M.W. Brechbiel Gadolinium-labeled dendrimers as biometric nanoprobes to detect vascular permeability J. Mater. Chem. 13 2003 1523 1525
67. L.D. Margerum, B.K. Campion, M. Koo, N. Shargill, J.J. Lai, A. Marumoto, and P.C. Sontum Gadolinium (III) DO3A macrocycles and polyethylene glycol coupled to dendrimers - effect of molecular weight on physical and biological properties of macromoleuclar resonance imaging contrast agents J. Alloys Compd. 249 1997 185 190
68. R. Esfand, D.A. Tomalia, and J.R.J. Baker Inhibition of viral adhesion and infection by sialic-acid-conjugated dendritic polymers Bioconjug. Chem. 10 1999 271 278
69. R.D. Kensinger, B.J. Catalone, F.C. Krebs, B. Wigdahl, and C.L. Schengrund Novel polysulfated galactose-derivatized dendrimers as binding antagonists of human immunodeficiency virus type 1 infection Antimicrob. Agents Chemother. 48 2004 1614 1623
70. A.E. Beezer, A.S.H. King, I.K. Martin, J.C. Mitchel, L.J. Twyman, and C.F. Wain Dendrimers as potential drug carriers; encapsulation of acidic hydrophobes within water soluble PAMAM derivatives Tetrahedron 59 2003 3873 3880
71. B. Devarakonda, R.A. Hill, and M.M. de Villiers The effect of PAMAM dendrimer generation size and surface functional group on the aqueous solubility of nifedipine Int. J. Pharm. 284 2004 133 140
72. K.T. Al-Jamal, T. Sakthivel, and A.T. Florence Dendrisomes: cationic lipidic dendron vesicular assemblies Int. J. Pharm. 254 2003 33 36
73. T. Ooya, J. Lee, and K. Park Hydrotropic dendrimers of generations 4 and 5: synthesis, characterization, hydrotropic solubilization of paclitaxel Bioconjug. Chem. 15 2004 1221 1229
74. A. D'Emanuele, R. Jevprasesphant, J. Penny, and D. Attwood The use of a dendrimer-propranolol prodrug to bypass efflux transporters and enhance oral bioavailability J. Control. Release 95 2004 447 453
75. A.S. Chauhan, S. Sridevi, K.B. Chalasani, A.K. Jain, S.K. Jain, N.K. Jain, and P.V. Diwan Dendrimer-mediated transdermal delivery: enhanced bioavailability of indomethacin J. Control. Release 90 2003 335 343
76. Z.X. Wang, Y.S. Itoh, Y. Hosaka, I. Kobayashi, Y. Nakano, I. Maeda, F. Umeda, J. Yamakawa, M. Nishimine, T. Suenobu, S. Fukuzumi, M. Kawase, and K. Yagi Mechanism of enhancement effect of dendrimer on transdermal drug permeation through polyhydroxyalkanoate matrix J. Biosci. Bioeng. 96 2003 537 540
77. R.J. Marano, N. Wimmer, P.S. Kearns, B.G. Thomas, I. Toth, M. Brankov, and P.E. Rakoczy Inhibition of in vitro VEGF expression and choroidal neovascularization by synthetic dendrimer peptide mediated delivery of a sense oligonucleotide Exp. Eye Res. 79 2004 525 535
78. S. Shaunak, S. Thomas, E. Gianasi, A. Godwin, E. Jones, R. Duncan, P. Luthert, S. Patterson, P. Khaw, and S. Brocchini Polyvalent dendrimer glucosamine conjugates prevent scar tissue formation Nat. Biotechnol. 22 2004 1 8
79. J.P. Tam Synthetic peptide vaccine design, synthesis and properties of a high density multiple antigenic peptide system Proc. Natl. Acad. Sci. U. S. A. 85 1988 5409 5413
80. H. Zhao, J.R. Li, F. Xi, and L. Jiang Polyamidoamine dendrimers inhibit binding of Tat peptide to TAR RNA FEBS Lett. 563 2004 241 245
81. M. Zhou, and I. Ghosh Noncovalent multivalent assembly of Jun peptides on a leucine Zipper dendrimer displaying Fos peptides Org. Lett. 6 2004 3561 3564
82. S. Higashiyama, K. Isoda, M. Kawase, and K. Yagi Development of custom-made scaffolds for mammalian cells using ligand-modified polyamidoamine dendrimers Kobunshi Ronbunshu 61 2004 587 594
83. D.F. Williams A model of biocompatibility and its evaluation J. Biomed. Eng. 11 1989 185 191
84. B. Rihova Biocompatibility of biomaterials: haematocompatibility, immunocompatibility, and biocompatibility of solid polymeric materials and soluble targetable polymeric carriers Adv. Drug Deliv. Rev. 21 1996 157 176
85. B. Rihova, K. Ulbrich, J. Kopecek, and P. Mancal Immunogenicity of N-(2-hydroxypropyl)methacrylamide copolymers - potential hapten or drug carriers Folia Microbiol. 28 1983 7 297
86. B. Rihova, J. Kopecek, K. Ulbrich, J. Pospisil, and P. Mancal Effect of the chemical structure of N-(2-hydroxypropyl)methacrylamide copolymers on their ability to induce antibody formation in inbred strains of mice Biomaterials 5 1984 143 148
87. B. Rihova, J. Kopecek, K. Ulbrich, and V. Chytry Immunogenicity of N-(2-hydroxypropyl)methacrylamide copolymers Makromol. Chem. 9 1985 13 24
88. P.A. Flanagan, R. Duncan, B. Rihova, V. Subr, and J. Kopecek Immunogenicity of protein-N-(2-hydroxypropyl)methacrylamide copolymer conjugates measured in A/J and B10 mice J. Bioact. Compat. Polym. 5 1990 151 166
89. J. Simeckova, D. Plocova, B. Rihova, and J. Kopecek Activity of complement in the presence of N-(2-hydroxypropyl)methacrylamide copolymers J. Bioact. Compat. Polym. 1 1986 20 31
90. B. Rihova, K. Ulbrich, J. Strohalm, V. Vetvicka, M. Bilej, R. Duncan, and J. Kopecek Biocompatibility of N-(2-hydroxypropyl)methacrylamide copolymers containing adriamycin. Immunogenicity, effect of haematopoietic stem cells in bone marrow in vivo and effect on mouse splenocytes and human peripheral blood lymphocytes in vitro Biomaterials 10 1989 335 342
91. L. Seymour, R. Duncan, J. Strohalm, and J. Kopecek Effect of molecular weight (Mw) of N-(2-hydroxypropyl)methacrylamide copolymers on body distributions and rate of excretion after subcutaneous, intraperitoneal and intravenous administration to rats J. Biomed. Mater. Res. 21 1987 1341 1358
92. P. Goddard, I. Williamson, J. Brown, L. Hutchinson, J. Nicholls, and K. Petrak Soluble polymeric carriers for drug delivery: part 4. Tissue autoradiography and following intravenous administration J. Bioact. Compat. Polym. 6 1991 4 24
93. R. Duncan Polymer-drug conjugates D. Budman H. Calvert E. Rowinsky Handbook of Anticancer Drug Development 2003 Lippincott, Williams & Wilkins 239 260
94. R. Duncan, J.K. Coatsworth, and S. Burtles Preclinical toxicology of a novel polymeric antitumour agent: HPMA copolymer-doxorubicin (PK1) Human Exp. Toxicol. 17 1998 93 104
95. T.K. Yeung, J.W. Hopewell, R.H. Simmonds, L.W. Seymour, R. Duncan, O. Bellini, M. Grandi, F. Spreafico, J. Strohalm, and K. Ulbrich Reduced cardiotoxicity of doxorubicin given in the form of N-(2-hydroxypropyl) methacrylamide conjugates: an experimental study in the rat Cancer Chemother. Pharmacol. 29 1991 105 111
96. D. Sgouras, and R. Duncan Methods for the evaluation of biocompatibility of soluble synthetic polymers which have potential for biomedical use: 1. Use of the tetrazolium-based colorimetric assay (MTT) as a preliminary screen for the evaluation of in vitro cytotoxicity J. Mater. Sci. Med. 1 1990 67 78
97. R. Duncan, M. Bhakoo, M.L. Riley, and A. Tuboku-Metzger Soluble polymeric drug carriers: haematocompatibility J.C. Gomez-Fernandez D. Chapman L. Packer Progress in Membrane Biotechnology 1991 Birkhauser Verlag Basel 121 129
98. J. Haensler, and F.C. Szoka Jr. Polyamidoamine cascade polymers mediate efficient transfection of cells in culture Bioconjug. Chem. 4 1993 372 379
99. J.C. Roberts, M.K. Bhalgat, and R.T. Zera Preliminary biological evaluation of polyamidoamine (PAMAM) Starburst™ dendrimers J. Biomed. Mater. Res. 30 1996 53 65
100. 125I-labelled polyamidoamine dendrimers in vivo J. Control. Release 65 2000 133 148
101. J.S. Choi, K. Nam, J. Park, J.B. Kim, J.K. Lee, and J. Park Enhanced transfection efficiency of PAMAM dendrimer by surface modification with l-arginine J. Control. Release 99 2004 445 456
102. D. Fischer, T. Bieber, Y. Li, H.-P. Elsasser, and T. Kissel A novel non-viral vector for DNA delivery based on low molecular weight, branched polyethylenimine: effect of molecular weight on transfection and cytotoxicity Pharm. Res. 16 1999 1273 1279
103. D. Fischer, Y.X. Li, B. Ahlemeyer, J. Krieglstein, and T. Kissel In vitro cytotoxicity testing of polycations: influence of polymer structure on cell viability and hemolysis Biomaterials 24 2003 1121 1131
104. H.T. Chen, M.F. Neerman, A.R. Parrish, and E.E. Simanek Cytotoxicity, hemolysis, and acute in vivo toxicity of dendrimers based on melamine, candidate vehicles for drug delivery J. Am. Chem. Soc. 126 2004 10044 10048
105. R. Jevprasesphant, J. Penny, D. Attwood, N.B. McKeown, and A. D'Emanuele Engineering of dendrimer surfaces to enhance transepithelial transport and reduce cytotoxicity Pharm. Res. 20 2003 1543 1550
106. R. Jevprasesphant, J. Penny, R. Jalal, D. Attwood, N.B. McKeown, and A. D'Emanuele The influence of surface modification on the cytotoxicity of PAMAM dendrimers Int. J. Pharm. 252 2003 263 266
107. S. Fuchs, T. Kapp, H. Otto, T. Schoneberg, P. Franke, R. Gust, and A.D. Schluter A surface-modified dendrimer set for potential application as drug delivery vehicles: synthesis, in vitro toxicity, and intracellular localization Chem.-A Eur. J. 10 2004 1167 1192
108. S.P. Hong, A.U. Bielinska, A. Mecke, B. Keszler, J.L. Beals, X.Y. Shi, L. Balogh, B.G. Orr, J.R. Baker, and M.M.B. Holl Interaction of poly(amidoamine) dendrimers with supported lipid bilayers and cells: hole formation and the relation to transport Bioconjug. Chem. 15 2004 774 782
109. H. Lee, Y.-B. Lim, J.S. Choi, Y. Lee, T.-I. Kim, H.J. Kim, J.K. Yoon, K. Kim, and J.-S. Park Polyplexes assembled with internally quaternized PAMAM-OH dendrimer and plasmid DNA have a neutral surface and gene delivery potency Bioconjug. Chem. 14 2003 1214 1221
110. M. Xyloyiannis, O.L. Padilla de Jesus, J.M.J. Frechet, and R. Duncan PEG-dendron architecture influences endocytic capture and intracellular trafficking Proc. Int. Symp. Control. Release Bioact. Mater. 30 2003 149
111. C. Plank, K. Mechtler, F.C. Szoka, and E. Wagner Activation of the complement system by synthetic DNA complexes: a potential barrier to intravenous gene delivery Hum. Gene Ther. 7 1996 1437 1446
112. H. Eliyahu, N. Servel, A.J. Domb, and Y. Barenholz Lipoplex-induced hemagglutination: potential involvement in intravenous gene delivery Gene Ther. 9 2002 850 858
113. R. Wiwattanapatapee, B. Carreno-Gomez, N. Malik, and R. Duncan Anionic PAMAM dendrimers rapidly cross adult rat intestine in vitro: a potential oral delivery system Pharm. Res. 17 2000 991 998
114. J.B. Lloyd Lysosome membrane permeability: implications for drug delivery Adv. Drug Deliv. Rev. 41 2000 189 200
115. R. Jevprasesphant, J. Penny, D. Attwood, and A. D'Emanuele Transport of dendrimer nanocarriers through epithelial cells via the transcellular route J. Control. Release 97 2004 259 267
116. M. El-Sayed, C.A. Rhodes, M. Ginski, and H. Ghandehari Transport mechanism(s) of poly (amidoamine) dendrimers across Caco-2 cell monolayers Int. J. Pharm. 265 2003 151 157
117. P. Seib, Endocytosis and trafficking of polymer therapeutics in melanoma cells, PhD Thesis, Cardiff University (2005).
118. M. Manunta, P.H. Tan, P. Sagoo, K. Kashefi, and A.J.T. George Gene delivery by dendrimers operates via a cholesterol dependent pathway Nucleic Acids Res. 32 9 2004 2730 2739
119. A. Astriab-Fisher, D. Sergueev, M. Fisher, B.R. Shaw, and R.L. Juliano Conjugates of antisense oligonucleotides with the Tat and antennapedia cell-penetrating peptides: effects on cellular uptake, binding to target sequences, and biologic actions Pharm. Res. 19 6 2002 744 754
120. L.M. Santhakumaran1, T. Thomas, and T.J. Thomas Enhanced cellular uptake of a triplex-forming oligonucleotide by nanoparticle formation in the presence of polypropylenimine dendrimers Nucleic Acids Res. 32 2004 2102 2112
121. D.S. Wilbur, P.M. Pathare, D.K. Hamlin, K.R. Buhler, and R.L. Vessella Biotin reagents for antibody pretargeting. 3. Synthesis, radioiodination, and evaluation of biotinylated starburst dendrimers Bioconjug. Chem. 9 6 1998 813 825
122. N. Sato, H. Kobayashi, A. Hiraga, T. Saga, K. Togashi, J. Konishi, and M.W. Brechbiel Pharmacokinetics and enhancement patterns of macromolecular MR contrast agents with various sizes of polyamidoamine dendrimer cores Magn. Reson. Med. 46 2001 1169 1173
123. H. Kobayashi, N. Sato, S. Kawamoto, T. Saga, A. Hiraga, T.L. Haque, T. Ishimori, J. Konishi, K. Togashi, and M.W. Brechbiel A novel intravascular macromolecular MR contrast agent with generation-4 polyamidoamine dendrimer core: accelerated renal excretion with co-injection of lysine Magn. Reson. Med. 46 2001 457 464
124. H. Kobayashi, S. Kawamoto, S. Jo, N. Sato, T. Saga, A. Hiraga, J. Konishi, S. Hu, K. Togashi, M.W. Brechbiel, and R.A. Star Renal tubular damage detected by dynamic micro-MRI with a dendrimer-based MR contrast agent Kidney Int. 61 2002 1980 1985
125. H. Kobayashi, S. Kawamoto, T. Saga, N. Sato, A. Hiraga, T. Ishimori, Y. Akita, M.H. Mamede, J. Konishi, K. Togashi, and M.W. Brechbiel Novel liver macromolecular MR contrast agent with a polypropylenimine diaminobutyl dendrimer core: comparison to the vascular MR contrast agent with the polyamidoamine dendrimer core Magn. Reson. Med. 46 2001 795 802
126. J. Capala, R.F. Barth, M. Bendayan, M. Lauzon, D. Adams, A.H. Soloway, and J. Carlsson Boronated epidermal growth factor as a potential targeting agent for boron neutron capture therapy of brain tumours Bioconjug. Chem. 7 1996 7 15
127. Y. Matsumura, and H. Maeda A new concept for macromolecular therapeutics in cancer chemotherapy; mechanism of tumoritropic accumulation of proteins and the antitumour agent SMANCS Cancer Res. 6 1986 6387 6392
128. M. El-Sayed, M.F. Kiani, M.D. Naimark, A.H. Hikal, and H. Ghandehari Extravasation of poly(amidoamine) (PAMAM) dendrimers across microvascular network endolethium Pharm. Res. 18 1 2001 23 28
129. S. Ota, T. Ono, A. Morita, A. Uenake, M. Harada, and E. Nakayama Cellular processing of a multibranched lysine core with tumor antigen peptides and presentation of peptide epitopes recognized by cytotoxic T lymphocytes on antigen-presenting cells Cancer Res. 62 2002 1471 1476
130. S. Bay, R. Lo-Man, E. Osinaga, H. Nakada, C. Lecherc, and D. Cantacuzene Preparation of a multiple antigen glycopeptide (MAG) carrying the Tn antigen - a possible approach to a synthetic carbohydrate vaccine J. Pept. Res. 49 1997 620 625
131. D.S. Breslow Biologically active synthetic polymers Pure Appl. Chem. 46 1976 103 113
132. R. Roy Recent developments in the rational design of multivalent glycoconjugates Top. Curr. Chem. 187 1997 241 274
133. M. Pospisil, L. Vannucci, A. Fiserova, K. Krausova, O. Horvath, V. Kren, F. Mosca, T.K. Lindhorst, K. Sadalapure, and K. Bezouska Glycodendrimeric ligands of c-type lectin receptors as therapeutic agents in experimental cancer Adv. Exp. Med. Biol. 495 2001 343 347
134. M. Witvrouw, V. Fikkert, W. Pluymers, B. Matthews, K. Mardel, D. Schols, J. Raff, Z. Debyser, E. De Clercq, G. Holan, and C. Pannecouque Polanionic (i.e. polysulfonate) dendrimers can inhibit the replication of human immunodeficiency virus by interfering with both virus adsorption and later steps (reverse transcriptase/integrase) in the virus replicative cycle Mol. Pharmacol. 58 2000 1100 1108
135. R.D. Kensinger, B.J. Catalone, F.C. Krebs, B. Wigdahl, and C.-L. Schengrund Novel polysulfated galactose-derivatized dendrimers as binding antagonists of human immunodeficiency virus type-1 infection Antimicrob. Agents Chemother. 48 2004 1614 1623
136. N. Bourne, L.R. Stanberry, E.R. Kern, G. Holan, B. Matthews, and D.I. Bernstein Dendrimers a new class of candidate topical microbicides with activity against herpes simplex virus infection Antimicrob. Agents Chemother. 44 2000 2471 2474
137. H. Baigude, K. Katsuraya, K. Okuyama, K. Hatanaka, E. Ikeda, N. Shibata, and T. Uryu Synthesis of spherical and hemispherical sugar-containing poly(ornithine) dendrimers J. Polym. Sci. Part A-Polym. Chem. 42 6 2004 1400 1414
138. Y.G. Li, Y.D. Tseng, S.Y. Kwon, L. D'Espaux, J.S. Bunch, P.L. Mceuen, and D. Luo Controlled assembly of dendrimer-like DNA Nat. Mater. 3 1 2004 38 42
139. H. Sashiwa, H. Yajima, and S. Aiba Synthesis of a chitosan-dendrimer hybrid and its biodegradation Biomacromolecules 4 5 2003 1244 1249
140. E.R. Gillies, and J.M.J. Frechet Designing macromolecules for therapeutic applications: polyester dendrimer-poly(ethylene oxide) "bow-tie" hybrids with tunable molecular weight and architecture J. Am. Chem. Soc. 154 2002 14137 14146
141. F. Sanchez-Sancho, E. Perez-Inestrosa, R. Suau, C. Mayorga, M.J. Torres, and M. Blanca Dendrimers as carrier protein mimetics for IgE antibody recognition. Synthesis and characterization of densely penicilloylated dendrimers Bioconjug. Chem. 13 3 2002 647 653
142. V. Balzani, P. Ceroni, M. Maestri, C. Saudan, V. Vicinelli, Luminescent dendrimers. Recent advances. Dendrimers: V. Functional and Hyperbranched Building Blocks, Photophysical Properties, Appl. Mater. and Life Sci. Topics in Current Chem. 228 (2003) 159-191.
143. J.O. McIntyre, B. Fingleton, K.S. Wells, D.W. Piston, C.C. Lynch, S. Gautam, and L.M. Matrisian Development of a novel fluorogenic proteolytic beacon for in vivo detection and imaging of tumour-associated matrix metalloproteinase-7 activity Biochem. J. 377 2004 617 628
144. T.P. Thomas, A.K. Patri, A. Myc, M.T. Myaing, J.Y. Ye, T.B. Norris, and J.R. Baker In vitro targeting of synthesized antibody-conjugated dendrimer nanoparticles Biomacromolecules 5 6 2004 2269 2274
145. W. Tansey, S. Ke, X.Y. Cao, M.J. Pasuelo, S. Wallace, and C. Li Synthesis and characterization of branched poly(l-glutamic acid) as a biodegradable drug carrier J. Control. Release 94 1 2004 39 51
146. F.P. Seib, A.T. Jones, and R. Duncan Endocytic capture and intracellular trafficking: effect of polymer architecture Proc. Int. Symp. Control. Release Bioact. Mater. 31 2004 717